Scientists from Sanford Burnham Prebys have created natural-looking hair that grows through the skin using human induced pluripotent stem cells (iPSCs), a major scientific achievement that could revolutionize the hair growth industry.
The findings were presented today at the annual meeting of the International Society for Stem Cell Research (ISSCR) and received a Merit Award. A newly formed company, Stemson Therapeutics, has licensed the technology.
More than 80 million men, women and children in the United States experience hair loss. Genetics, aging, childbirth, cancer treatment, burn injuries and medical disorders such as alopecia can cause the condition. Hair loss is often associated with emotional distress that can reduce quality of life and lead to anxiety and depression.
“Our new protocol described today overcomes key technological challenges that kept our discovery from real-world use,” says Alexey Terskikh, Ph.D., an associate professor in Sanford Burnham Prebys’ Development, Aging and Regeneration Program and the co-founder and chief scientific officer of Stemson Therapeutics. “Now we have a robust, highly controlled method for generating natural-looking hair that grows through the skin using an unlimited source of human iPSC-derived dermal papilla cells. This is a critical breakthrough in the development of cell-based hair-loss therapies and the regenerative medicine field.”
Terskikh studies a type of cell called dermal papilla. Residing inside the hair follicle, these cells control hair growth, including hair thickness, length and growth cycle. In 2015, Terskikh successfully grew hair underneath mouse skin (subcutaneous) by creating dermal papilla derived from human pluripotent stem cells—a tantalizing but uncontrolled process that required further refinement.
The approach detailed in the ISSCR presentation, which was delivered by lead researcher Antonella Pinto, Ph.D., a postdoctoral researcher in the Terskikh lab, features a 3D biodegradable scaffold made from the same material as dissolvable stitches. The scaffold controls the direction of hair growth and helps the stem cells integrate into the skin, a naturally tough barrier. The current protocol relies on mouse epithelial cells combined with human dermal papilla cells. The experiments were conducted in immunodeficient nude mice, which lack body hair.
The derivation of the epithelial part of a hair follicle from human iPSCs is currently underway in the Terskikh lab. Combined human iPSC-derived epithelial and dermal papilla cells will enable the generation of entirely human hair follicles, ready for allogenic transplantation in humans. Distinct from any other approaches to hair follicle regeneration, human iPSCs provide an unlimited supply of cells and can be derived from a simple blood draw.
“Hair loss profoundly affects many people’s lives. A significant part of my practice involves both men and women who are seeking solutions to their hair loss,” says Richard Chaffoo, M.D., F.A.C.S., a triple board-certified plastic surgeon who founded La Jolla Hair MD and is a medical adviser to Stemson Therapeutics. “I am eager to advance this groundbreaking technology, which could improve the lives of millions of people who struggle with hair loss.”
The technology was discovered and developed at Sanford Burnham Prebys. Further development and commercialization activities will be conducted by Stemson Therapeutics. For updates on the technology’s progress and advancement, please visit www.stemsontx.com.
Learn more: Functional hair follicles grown from stem cells
The Latest on: Induced pluripotent stem cells
via Google News
The Latest on: Induced pluripotent stem cells
- Stem cell breakthrough offers hope for critically endangered wildlife specieson February 22, 2021 at 9:38 pm
A paper recently published in the scientific journal Stem Cells and Development shares an important advancement in conservation -- one that may make the difference between survival and extinction for ...
- Stem cells provide hope for dwindling wildlife populationson February 22, 2021 at 1:45 pm
A paper recently published in the scientific journal Stem Cells and Development shares an important advancement in conservation—one that may make the difference between survival and extinction for ...
- Human induced pluripotent stem cell-based platform for modeling cardiac ischemiaon February 18, 2021 at 2:16 pm
Many therapeutics that have been promising in animal models have failed in human trials. Thus, functional human based cardiac ischemia models are required. In this study, a human induced pluripotent ...
- India $470 Million Stem Cell Market Competition Forecast & Opportunities, 2021-2026on February 16, 2021 at 1:21 am
The "India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User, By Technology, ...
- Induced Pluripotent Stem Cells Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027on February 10, 2021 at 6:22 am
The report for Induced Pluripotent Stem Cells offers an assiduous analysis of contemporary market trends, driving factors, consumer behavior, key player strategies, product usage and brand positioning ...
- Notch Therapeutics Closes $85 Million Series A Financing to Develop Pipeline of Renewable Stem Cell-Derived Cancer Immunotherapieson February 10, 2021 at 4:00 am
Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for ...
- Scientists grow small intestinal cells from human-induced pluripotent stem cellson February 8, 2021 at 2:47 am
A team of scientists from Japan have found success in growing small intestinal cells, akin to those found in the human body, from human-induced pluripotent stem cells. The scientists used a ...
- Researchers grow intestinal cells from human-induced pluripotent stem cellson February 7, 2021 at 4:00 pm
Human-induced pluripotent stem cells derived enterocyte-like cells exhibit P-gp- and BCRP-mediated efflux and cytochrome P450 (CYP3A4)-mediated metabolism. We concluded that hiPS cell-derived ...
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cellson February 4, 2021 at 4:00 pm
are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have ...
- Generation of human oogonia from induced pluripotent stem cells in vitroon February 3, 2021 at 4:00 pm
See allHide authors and affiliations Human pluripotent stem cells (hPSCs) have been induced into human primordial germ cell–like cells (hPGCLCs) in vitro, the first step toward human in vitro ...
via Bing News